Biofrontera Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 330.3%.

Top 20 shareholders own 60.36% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.1%	Laurence Lytton	504,337	€492.4k	0%	no data
9.1%	Lytton-Kambara Foundation, Endowment Arm	504,271	€492.4k	0%	62.31%
9.09%	Martin Chopp	504,168	€492.3k	0%	no data
9.05%	Aigh Capital Management, LLC	501,434	€489.6k	0%	0.21%
7.68%	Rosalind Advisors, Inc.	426,002	€416.0k	-14%	0.24%
7.22%	Biofrontera AG	400,000	€390.6k	0%	no data
2.84%	Abshagen-Consulting GmbH	157,402	€153.7k	0%	no data
2.71%	Armistice Capital LLC	150,000	€146.5k	0%	no data
1.06%	Deutsche Balaton AG	58,884	€57.5k	0%	0.02%
0.9%	Scotiabank Global Banking and Markets, Asset Management Division	50,000	€48.8k	-58.3%	no data
0.54%	Matejka & Partner Asset Management GmbH	30,000	€29.3k	0%	0.06%
0.31%	Geode Capital Management, LLC	17,102	€16.7k	-2.51%	no data
0.27%	Hermann Luebbert	15,211	€14.9k	0%	no data
0.18%	Bigger Capital, LLC	10,000	€9.8k	-96%	0.06%
0.16%	The Vanguard Group, Inc.	8,611	€8.4k	0%	no data
0.083%	BlackRock, Inc.	4,622	€4.5k	0%	no data
0.056%	UBS Asset Management AG	3,099	€3.0k	-69.1%	no data
0.01%	Osaic Wealth, Inc. , Asset Management Arm	576	€562.4	0%	no data
0.005%	Tower Research Capital Europe Limited	276	€269.6	-97.4%	no data
0.00043%	Bank of America Corporation, Asset Management Arm	24	€23.3	0%	no data